An Enduring Legacy of Hope and Impact
Chike Springer was many things — a husband, son, brother, uncle and patriot — but he was most known for his positivity and determination.
News
U.S. Food and Drug Administration Approves Loncastuximab Tesirine-lpyl for Large B-cell Lymphoma
Loncastuximab tesirine-lpyl is the first and only CD-19-directed antibody drug conjugate single agent approved for relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
Ask the Doctor: How can we determine the efficacy of the COVID-19 vaccine and how we may respond?
As the rollout of the new COVID-19 vaccines continues, there is constant new data related to the vaccines and their effects on individuals. While most of this data is preliminary, information related to the efficacy and effect of the vaccine…
Ask the Doctor: How do physicians determine when follicular lymphoma has transformed to DLBCL? What kind of tests or symptoms help doctors monitor this?
Transformed lymphoma occurs when an indolent lymphoma turns into a more aggressive one. A transformation occurs when genetic changes in the indolent lymphoma cells cause them to begin growing faster and behaving more aggressively. Lymphoma Research Foundation Grantee Raphael Eric…
LRF Honors Michael E. Williams, MD with Mantle Cell Lymphoma Leadership Award
World-renowned hematologist/oncologist receives inaugural award for outstanding commitment in the field of mantle cell lymphoma research and patient care.
Ask the Doctor: What is the current efficacy of oral therapies for marginal zone lymphoma?
There are several chemotherapy and targeted anticancer drugs approved or under investigation for the treatment of lymphoma. Unlike traditional chemotherapy that is administered intravenously (IV) in a hospital or clinic, oral therapies are administered via a pill, taken at home…
Lymphoma Research Foundation Funds 29 New Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity Initiative
Investment supports early-career scientists dedicated to developing patient therapies and lymphoma cures.
Lymphoma Research Foundation Unites Lymphoma Community Nationwide Through Lymphoma Walk Program, Walk On! America
Thousands to Raise Awareness and Funds through Virtual Celebration and Socially Distanced Neighborhood Walks The Lymphoma Research Foundation (LRF) will offer Walk On! America, a twist on its Spring 2021 Team LRF Lymphoma Walks to bring the lymphoma community together safely in the time of COVID-19. Lymphoma…
U.S. Food and Drug Administration Approves CAR T Cell Therapy for Follicular Lymphoma
Axicabtagene ciloeucel has been approved for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL).
Best Shot: A Story of Hope
When Chris Gorelik received news that his central nervous system lymphoma would leave him with months to live, he sought a second opinion and took a chance on a new treatment protocol — to give him a fighting chance to see his children grow up.